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Addenbrooke’s Hospital, Hill’s Road, Cambridge CB2 2QQ, UKAbstract—The knowledge that diverse populations of dopa-
minergic neurons within the ventral tegmental area (VTA)
can be distinguished in terms of their molecular, electro-
physiological and functional properties, as well as their
diﬀerential projections to cortical and subcortical regions
has signiﬁcance for key brain functions, such as the regula-
tion of motivation, working memory and sensorimotor
control. Almost without exception, this understanding has
evolved from landmark studies performed in the male sex.
However, converging evidence from both clinical and
pre-clinical studies illustrates that the structure and func-
tioning of the VTA dopaminergic systems are intrinsically
diﬀerent in males and females. This may be driven by sex
diﬀerences in the hormonal environment during adulthood
(‘activational’ eﬀects) and development (perinatal and/or
pubertal ‘organizational’ eﬀects), as well as genetic factors,
especially the SRY gene on the Y chromosome in males,
which is expressed in a sub-population of adult midbrain
dopaminergic neurons. Stress and stress hormones,
especially glucocorticoids, are important factors which
interact with the VTA dopaminergic systems in order tohttp://dx.doi.org/10.1016/j.neuroscience.2014.05.033
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69achieve behavioral adaptation and enable the individual
to cope with environmental change. Here, also, there is
male/female diversity not only during adulthood, but also
in early life when neurobiological programing by stress or
glucocorticoid exposure diﬀerentially impacts dopaminer-
gic developmental trajectories in male and female brains.
This may have enduring consequences for individual resil-
ience or susceptibility to pathophysiological change
induced by stressors in later life, with potential translational
signiﬁcance for sex bias commonly found in disorders
involving dysfunction of the mesocorticolimbic dopaminer-
gic systems. These ﬁndings highlight the urgent need for
a better understanding of the sexual dimorphism in the
VTA if we are to improve strategies for the prevention and
treatment of debilitating conditions which diﬀerentially
aﬀect men andwomen in their prevalence and nature, including
schizophrenia, attention/deﬁcit hyperactivity disorder, autism
spectrum disorders, anxiety, depression and addiction.
This article is part of a Special Issue entitled: Ventral
Tegmentum & Dopamine.  2014 The Authors. Published
by Elsevier Ltd. on behalf of IBRO. This is an open access
article under the CC BY license (http://creativecommon-
s.org/licenses/by/3.0/).
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70 G. E. Gillies et al. / Neuroscience 282 (2014) 69–85INTRODUCTION projects to the ventral striatum, especially the nucleusThe last half of the twentieth century saw an exponential
rise in the scientiﬁc evidence for sex diﬀerences in the
brain. Yet, the implications of these ﬁndings were
ignored, if not suppressed, largely due to the politically
correct notion that claims for brain sex diﬀerences
challenged equality and were retrogressive (Kimura,
1992; Moir and Jessel, 1992; McCarthy et al., 2012).
However, it is increasingly apparent that neurological
and neuropsychiatric disorders show signiﬁcant sex diﬀer-
ences in susceptibility, prevalence, presentation (symp-
toms), progression, pathology and response to
treatments (Cahill, 2006; Cosgrove et al., 2007; Gillies
and McArthur, 2010b; Ngun et al., 2011; Becker et al.,
2012; McCarthy et al., 2012). This has led to the realiza-
tion that diﬀerent preventive, diagnostic and treatment
approaches may be required for men and women, which,
in turn, highlights the urgent need for a better understand-
ing of speciﬁc pathways that exhibit biological sex diﬀer-
ences in the brain, along with mechanisms which
generate these diﬀerences (Health, 2011). The goal of
this review is to consider sex, distinguished as being male
or female according to reproductive organs and chromo-
somal complement (male XY and female XX sex chromo-
somes), as a factor in diversity of the ventral tegmental
area (VTA), which impacts both the physiology and
pathology of the dopaminergic systems originating in the
VTA. We shall ﬁrst review the evidence for biological
sex dimorphisms in the normal dopaminergic network, fol-
lowed by the key factors (sex hormones and chromo-
somes) which underpin these diﬀerences. We then
provide a brief summary of sex diﬀerences in dopaminer-
gic malfunction, and develop the hypothesis that a sexu-
ally dimorphic response of the mesocorticolimbic system
to stressors and stress hormones, especially glucocorti-
coids, during adulthood or development represents a
mechanism which may contribute to sex biases com-
monly found in dopamine (DA)-associated disorders.SEX DIFFERENCES IN NORMAL MIDBRAIN
DOPAMINERGIC SYSTEMS
Sex diﬀerences in the hypothalamic circuitry governing
reproduction and mating behaviors are widely accepted
as being fundamental to the survival of dioescious
vertebrates. Mounting evidence now suggests that the
midbrain dopaminergic systems are also sexually
dimorphic. We have recently reviewed the molecular,
cellular and functional sex diﬀerences in the nigrostriatal
dopaminergic (NSDA) system, which originates in the
midbrain region of the substantia nigra pars compacta
(SNc) and projects to the dorsal striatum (Gillies and
McArthur, 2010a,b; McArthur and Gillies, 2011; Gillies
et al., 2014). This regulates sensorimotor function, and
its sexually dimorphic nature is thought to contribute to
sex diﬀerences in the prevalence and nature of Parkin-
son’s disease, where NSDA degeneration is a deﬁning
pathology (Dexter and Jenner, 2013). Emerging evidence
suggests that sex diﬀerences are also present in the
dopaminergic pathways originating in the adjacent VTA.
One sub-population of VTA dopaminergic neuronsaccumbens (NAc), to form the mesolimbic pathway,
which is a key regulator of emotional social behaviors,
reward-associated behaviors, motivation and feeding:
the other sub-population projects to the prefrontal cortex
to form the mesocortical pathway, which provides critical
regulation of cognition, and working memory (Robbins,
2000; Bjorklund and Dunnett, 2007; Everitt et al., 2008;
O’Connell and Hofmann, 2011). Studies in humans and
experimental animals provide considerable evidence for
sex diﬀerences in these behaviors, and the extent to
which this may involve sex diﬀerences in the mesocortico-
limbic system is considered in this section.
Humans
Sex diﬀerences in speciﬁc aspects of motivation, reward
cognition, behavior and aﬀect, have been reviewed in
detail elsewhere (Cahill and McGaugh, 1998; Sherwin,
2003; Cahill, 2006; Cosgrove et al., 2007; Guiso et al.,
2008; Sherwin and Henry, 2008; Hines, 2011b; Becker
et al., 2012). For example, women appear to be more
sensitive than men to the rewarding eﬀects of psychoac-
tive drugs, suggesting diﬀerences in dopaminergic activity
in the NAc as a potential contributory mechanism (Carroll
et al., 2004; Lynch, 2006; Becker and Hu, 2008). Diﬀer-
ences are also seen in prefrontal processes, such as
working memory, involving the mesocortical system.
These include sex diﬀerences in performance in tests of
verbal memory and visuospatial memory as well as man-
ual dexterity, which tend to show a female advantage
(Schattmann and Sherwin, 2007a), whereas men gener-
ally outperform women in spatial tasks requiring mental
re-orientation, as well as target-directed motor skills
(Kimura and Harshman, 1984; Kimura, 1992; Hines,
2011a). In humans, sociocultural factors may contribute
both to underlying diﬀerences in neurological develop-
ment as well as cognitive functions. However, even when
sociocultural diﬀerences have been accounted for, sex
diﬀerences in brain function may persist (Guiso et al.,
2008), and human behavioral sex diﬀerences also have
parallels in non-human mammalian species that lack
identical sociocultural pressures. Together, such observa-
tions argue for intrinsic factors as being primary drivers of
brain sex diﬀerences. Recent data from real-time in vivo
neuroimaging studies provide key, direct evidence that
fundamental sex diﬀerences in the midbrain dopaminergic
systems contribute to behavioral dimorphisms. For exam-
ple, although there appears to be little sex diﬀerence in
striatal DA release at rest, women were found to have
greater pre-synaptic DA synthetic capacity, striatal DA
transporter (DAT) density and accumulation of the DA
precursor radionuclide, F-Fluorodopa (FDOPA), com-
pared with men (Lavalaye et al., 2000; Mozley et al.,
2001; Laakso et al., 2002), whereas the aﬃnity of the
D2 receptor subtype was greater in men (Pohjalainen
et al., 1998). In healthy young subjects performing behav-
ioral tests associated with dopaminergic activity, neuroim-
aging studies found a relationship between striatal DA
availability and executive and motor functioning in
women, but not in men (Mozley et al., 2001). Signiﬁcant
sex diﬀerences were also found when correlating
Fig. 1. Sex diﬀerences in accumbal dopamine (DA) responses to amphetamine and impact of antenatal glucocorticoid treatment (AGT). Male and
female rats exposed to AGT (dexamethasone, 0.5 lg/ml, in drinking water on gestational days 16–19; closed symbols in the line plots and solid bars
in the bar plots) and controls (dams received normal drinking water; open symbols in the line plots and open bars in the bar plots) were tested in
adulthood. Extracellular levels of DA in the NAc were assessed by in vivo microdialysis coupled with electrochemical detection. Microdialysis
samples were collected every 20 min for 3 h and after the ﬁrst three fractions (baseline) amphetamine (0.8 mg/kg i.p.) was administered. The line
plots (A) depict DA levels in each 20-min fraction and the arrow indicates the point of amphetamine administration. The bar plot (B) shows
cumulative DA release above baseline (area under the curve, AUC). Data were used only from those animals where placement of the dialysis probe
in the core of the nucleus accumbens was conﬁrmed post-mortem; statistical analyses were adjusted accordingly for diﬀerences in group sizes.
Controls: Baseline levels of DA eﬄux were similar in males and females (A), whereas amphetamine-stimulated DA eﬄux was almost fourfold greater
in females compared with males (A, B). AGT: Baseline levels of DA eﬄux were unaﬀected by AGT, whereas amphetamine-stimulated eﬄux was
increased in males, but decreased in females compared with controls. Values represent means ± s.e.m for control males (n= 5), AGT males
(n= 6), control females (n= 4) and AGT females (n= 5). #p< 0.05, indicating a signiﬁcant sex diﬀerence; ⁄p< 0.05 indicating a signiﬁcant eﬀect
of AGT. For full details see Virdee et al. (2013).
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and extra-striatal regions after amphetamine administra-
tion (Riccardi et al., 2011). Functional neuroimaging stud-
ies have also linked sex diﬀerences in reward-related
behaviors to sex dimorphisms in the mesolimbic dopami-
nergic response, which were reported to be greater in
men than women (Munro et al., 2006; Diekhof et al.,
2012). Although investigations of this nature are in their
infancy, these observations suggest that there are intrin-
sic sex diﬀerences in basal DA neuron dynamics, and that
cognitive and motor functions may be diﬀerentially regu-
lated by midbrain DA systems in men and women. This
provides support for the concept that male and female
brains may be reliant on diﬀerent strategies to reach
the same goal, and that similar performance between
the sexes does not necessitate the same neural mecha-
nisms and information processing (Cahill, 2006).Pre-clinical studies
Investigations performed largely in rodents support,
extend, and even predict, the human data. For
example, investigations in gonad-intact rats using in vivo
microdialysis (Fig. 1A) (Virdee et al., 2013) or voltamme-
try (Walker et al., 2000, 2006), report no sex diﬀerences in
DA eﬄux in the NAc and striatum at rest, and striatal DA
content is similar in male and female striata (Murray et al.,
2003; Gillies et al., 2004; McArthur et al., 2005;
Kuhn et al., 2010). However, these similarities appear
to be achieved by a diﬀerent balance in dopaminergic
regulatory mechanisms, with a faster rate of uptake and
release in females (Walker et al., 2006). Additionally, fargreater extracellular levels of DA are found in females
compared with males treated with the indirectly acting
DA receptor agonists, amphetamine (Fig. 1) (Virdee
et al., 2013) or cocaine (Walker et al., 2006), which both
target DAT in the DA nerve terminals. Sex diﬀerences in
mesolimbic activity are also conﬁrmed using the typical
antipsychotic, haloperidol. This drug enhances electrically
stimulated DA signaling by blocking presynaptic, auto-
inhibitory D2 receptors which inhibit DA release and stim-
ulate uptake (Wu et al., 2002), and has a signiﬁcantly
greater eﬀect on the overﬂow of DA into the synapse in
females compared with males (Walker et al., 2006).
Together, these observations suggest that the sex dimor-
phisms of the mesolimbic dopaminergic system could
explain why psychoactive drugs, such as amphetamine
and cocaine, induce greater locomotor responses and
behavioral sensitization in female compared with male
rats (Bowman and Kuhn, 1996; Becker et al., 2001;
Walker et al., 2001), and why females show a greater
sensitivity to haloperidol-induced catalepsy (Campbell
et al., 1988).
Sex diﬀerences are also seen in performance in
cognitive tasks, such as working memory, which
measure prefrontal cortical processes (van Haaren
et al., 1990; Ceccarelli et al., 2001). To a certain extent,
these may reﬂect neuroanatomical sex diﬀerences which
have been identiﬁed in the rat mesocortical dopaminergic
system. For example, retrograde labeling studies to
identify the VTA DA neurons projecting to the prelimbic
area of the prefrontal cortex, the primary motor cortex
and the premotor cortex, revealed large sex diﬀerences
in the proportions of DA neurons making up all three
Fig. 2. Sex diﬀerences and impact of antenatal glucocorticoid treatment (AGT) on the total cell count and distribution of tyrosine hydroxylase-
immunoreactive (TH-IR) cells in the adult rat VTA. Brain slices containing the VTA from adult male and female rats exposed to AGT
(dexamethasone, 0.5 lg/ml, in drinking water on gestational days 16–19) and controls (dams received normal drinking water) were processed for
immunocytochemical detection of TH. The VTA was delineated by TH-IR and anatomical landmarks. In order to detect any regional diﬀerences
throughout the nucleus, coronal sections containing the VTA were divided into three levels, each spanning 300 lm, beginning at 5.1 mm (level 1),
5.4 mm (level 2) and 5.7 mm (level 3) with respect to bregma. Controls (A–C): Total TH-IR cell counts were signiﬁcantly greater in females (A).
The distribution of these cells was relatively uniform throughout the three levels in males, whereas a greater proportion was found at level 2 in
females. AGT (D–F): After AGT the total adult TH-IR cell counts were markedly increased in males and females, and their distribution across levels
1–3 was altered, which can be described as a rostro-caudal shift in cell number. N,., indicates signiﬁcant eﬀect of treatment, p< 0.05 increased or
decreased respectively for dexamethasone treated vs. control animals; + indicates signiﬁcant sex diﬀerence p< 0.05 vs. females in the same
treatment group. For full details see McArthur et al. (2005, 2007a).
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three regions the proportion of back-labeled cells in
females was approximately double than that seen in
males. Structural sex diﬀerences have also been reported
in the VTA, with females having a signiﬁcantly greater
number of DA perikarya (Fig. 2A), as well as a greater vol-
ume of this region, compared with males (McArthur et al.,
2007a). In addition, the overall shape of the VTA, as delin-
eated by the volumes occupied by the DA perikarya at dif-
ferent levels through the rostro-caudal axis of the nucleus,
as well as the distribution of the DA neurons at each level,
is sexually dimorphic, although the size of the individual
perikarya is similar between the sexes (McArthur et al.,
2007a) (Fig 2B). Overall, these cytoarchitectural diﬀer-
ences can be described as a rostro-caudal shift in the
volume and distribution of DA cells in females relative to
males. As the VTA comprises sub-sets of neurons with
region-speciﬁc input and output systems to govern its
multi-functionality (Bjorklund and Dunnett, 2007;
Roeper, 2013), these topographical diﬀerences may indi-
cate altered patterns of connectivity which could underpin
the neurochemical and behavioral sex diﬀerences.
Notably, the landmark studies on which we base our
understanding of the molecular, electrophysiological,
anatomical and functional diversity in the VTA (Roeper,
2013) have been carried out almost without exception(Fiorillo et al., 2008) in males. The foregoing discussion,
therefore, highlights that more studies are required to
understand the sexual diversity of the VTA.
MECHANISMS UNDERLYING SEXUAL
DIFFERENTIATION OF THE VTA
DOPAMINERGIC SYSTEMS
Gonadal steroid hormones are major drivers of sex
diﬀerences in the brain. It is well established that a transient
perinatal rise in testosterone production by the developing
testes is a principal factor in the masculinization/
defeminization of the brain (Fig. 3) (Wilson and Davies,
2007; McCarthy, 2008; Arnold, 2009; McCarthy and Arnold,
2011). Limited evidence suggests that similar events prevail
in the human fetus at a comparable stage of brain develop-
ment, around the time of mid-gestation (Gillies and
McArthur, 2010b). The processes which are aﬀected include
neurogenesis, neuralmigration, synaptogenesis, gliogenesis
andprogramedcell death. In contrast to thisearlyactivationof
the testes, ovarian steroidogenesis remains low at this stage
of development. Therefore, during a critical window, themale
and female brain develops in a very diﬀerent hormonal
environment, which leads to permanent diﬀerences in the
hard-wiring ofmale and female brains. Recent evidence sug-
gests that a second wave of irreversible, organizational inﬂu-
Fig. 3. Schematic representation of hormone-dependent sexual diﬀerentiation of the brain. Early in gestation the SRY gene on the Y sex
chromosome in males directs development of the testes. A transitory activation of the testes in males (but not the ovaries in females) during a critical
developmental window (just before and after birth in rodents; approximately mid-gestation in human and non-human primates) means that the brain
develops in a diﬀerent hormonal environment in males and females, which establishes irreversible sex dimorphisms in speciﬁc neural circuits. Rising
levels of gonadal steroids in the peripubertal period may exert further organizational eﬀects (especially estradiol in females). From puberty onward,
gonadal steroids activate the sexually dimorphic circuitry. This concept has arisen from extensive studies of hypothalamic circuitry controlling
reproduction and reproductive behaviors, sexual diﬀerentiation of which is fundamental for survival of the species. Evidence suggests that extra-
hypothalamic brain regions involved in learning and memory may also be subject to similar organizational and activational inﬂuences of gonadal
steroids during development and adulthood, respectively (Luine et al., 1986; McEwen, 1999; Bangasser and Shors, 2008; Mitsushima et al., 2009),
but how these principles apply speciﬁcally to the VTA dopaminergic system requires clariﬁcation.
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mone environment begins to become sexually dimorphic
once again with the rise of testosterone in males and estro-
gens and progesterone in females (Sisk and Zehr, 2005;
Juraska et al., 2013). This stage involves neuronal and glial
proliferation and morphological diﬀerentiation, as well as cell
death in speciﬁc brain regions, and is associated with an
active feminization of the brain, as distinct from the mascu-
linizing/defeminizing processes during the perinatal period,
although puberty may also include further masculinization.
The post-pubertal hormonal environment then further aug-
ments the underlying dimorphisms in brain structure and
functionviaactivational, reversible inﬂuencesof testosterone,
estrogensandprogesteronewhichdiﬀerentiallyaﬀect various
aspects of neurotransmission in males and females, such as
neurotransmitter synthesis, receptorexpressionandsynaptic
plasticity (McEwen, 1999, 2002; McEwen and Alves, 1999;
Pfaﬀ, 2005). Although these concepts of hormone-directed
sexual diﬀerentiation of the brain developed from studies of
thecentral control of reproductionand reproductivebehaviors
by the hypothalamus, it is now recognized that they aremore
widely applicable in regions throughout the brain. In the fol-
lowing sections the speciﬁc relevance of these concepts to
the VTA dopaminergic systems will be discussed, beginning
with the activational inﬂuences in adulthood, which provide
the bulk of the data. In addition, the dopaminergic systems
have been instrumental in revealing that genetic factors,
independent of sex hormones, also have a signiﬁcant role
to play in sexual diﬀerentiation of the VTA, which we summa-
rize brieﬂy.Sex hormone inﬂuences in adulthood
In humans and experimental species, many adult brain
functions, such as cognitive abilities, attention, mood,
reward and motivation, are inﬂuenced by the activational
inﬂuences of gonadal factors in both sexes (van Haaren
et al., 1990; McEwen, 1999, 2002, 2010; Sherwin, 2003;
Daniel, 2006; Caldu and Dreher, 2007; Craig and
Murphy, 2007; Luine, 2008; Brinton, 2009; Pike et al.,
2009; Becker et al., 2012). As the VTA dopaminergic sys-
tems contribute to these functions to varying degrees,
they are likely targets for hormone-dependent expression
of sexual dimorphism.The mesolimbic system. Women are more sensitive to
the rewarding eﬀects of psychoactive drugs than men
(Carroll et al., 2004; Lynch, 2006; Becker and Hu,
2008), and the pattern of activation of reward circuitry in
men diﬀered from that seen in women during both the
anticipation and delivery of rewards (Caldu and Dreher,
2007). In women the eﬀects of psychoactive drugs also
vary across the menstrual cycle (Carroll et al., 2004;
Lynch, 2006; Becker and Hu, 2008), and functional mag-
netic resonance imaging studies reveal an increased
responsiveness of the reward system to psychoactive
drugs during the mid-follicular phase of the menstrual
cycle, when estradiol levels are rising and relatively unop-
posed by progesterone (Caldu and Dreher, 2007). Overall
the data identify estrogens in women as a driving factor
for these diﬀerences, but the contribution of testosterone
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tively, the human data suggest that gonadal steroids play
an important role in driving sex diﬀerences in the adult
mesolimbic dopaminergic system through classical, acti-
vational eﬀects.
Animal studies conﬁrm and extend the human studies
and provide empirical support for the view that gonadal
factors may be acting on a sexually diﬀerentiated
mesolimbic dopaminergic circuitry (Becker, 1999; Gillies
and McArthur, 2010b; Becker et al., 2012). For example,
in female rats basal and amphetamine-stimulated con-
centrations of DA in the striatum (especially the NAc),
as well as behavioral responses to amphetamine (loco-
motor activity and stereotypy), are positively correlated
with endogenous estradiol levels as they ﬂuctuate over
the estrous cycle (Fink et al., 1996; Becker, 1999). More-
over, estradiol treatment reverses ovariectomy-induced
attenuation of these neurochemical and behavioral
responses (Xiao and Becker, 1994; Becker, 1999;
Ohtani et al., 2001). In females estradiol also increases
DA synthesis and turnover and markedly suppresses
the density of striatal DAT, which critically regulates DA
neuron dynamics (Pasqualini et al., 1995; McArthur
et al., 2007b). In contrast, neither castration nor treatment
of castrated rats with testosterone, or the non-
aromatizable dihydrotestosterone (DHT; an androgen
which, unlike testosterone cannot be metabolized to
estradiol by endogenous aromatase enzymes) or estra-
diol had any signiﬁcant eﬀect on these neurological or
behavioral parameters in males (Becker, 1999;
McArthur et al., 2007b). Furthermore, the sexually dimor-
phic responses to estradiol would indicate an innate
sexual diﬀerentiation of the underlying circuitry, most
likely imprinted by factors early in development (see
Section ‘Sex hormone inﬂuences during development’).
The mesocortical dopaminergic system. The
mesocortical dopaminergic system and the prefrontal
processes which it regulates, such as working memory,
are also subject to the activational inﬂuences of
circulating gonadal hormones in men and women
(Hampson, 1990; Janowsky, 2006). However, there is
no simple conclusion as to whether sex hormones facili-
tate, compromise or have no eﬀect on learning and mem-
ory. Additionally, eﬀects appear to be more complex than
those in the mesolimbic system, with both estrogens and
androgens reported to inﬂuence diﬀerent aspects of cog-
nition in women and men. In support of this, the brains of
men and women express both androgen receptors (ARs)
and estrogen receptors (ERs), with a similar, wide distri-
bution between the sexes (Simerly et al., 1990;
McEwen, 2002; Gillies and McArthur, 2010b). A periphe-
ral source of androgens, such as dehydroepiandrosterone
and androstenedione, comes from the adrenal glands in
both sexes as well as the ovaries (Labrie et al., 2005),
and in males estradiol can be synthesized from circulating
testosterone by aromatase enzymes located in tissues
throughout the body, including the brain (Simpson and
Jones, 2006). In addition, the brain itself can be consid-
ered a steroidogenic organ, because it possesses the
complement of steroid synthesizing enzymes, whichenables synthesis of estrogens and androgens de novo,
or by metabolism of peripherally derived precursors (Do
Rego et al., 2009; Pelletier, 2010). These observations
provide and infrastructure to explain why androgens in
women (Miller et al., 2006) and estrogens in men
(Cherrier et al., 2003) may inﬂuence mood and cognition,
as well as vice-versa. They also provide the rationale for
studying the eﬀects of androgens and estrogens in both
sexes.
Typically, human studies have investigated the eﬀects
of sex hormones on performance in memory tests which
show sex diﬀerences. The data show, for example, that
in young and older men DHT (a non-aromatizable
androgen acting principally at ARs), but not estradiol,
promoted performance in spatial visualization/memory
tasks (typically male advantage) (Cherrier et al., 2003,
2005), whereas elevated levels of androgens in young
women did not aﬀect their performance in such tasks
(Schattmann and Sherwin, 2007a, Schattmann and
Sherwin, 2007b). This could suggest that the activational
eﬀects of androgens in females were not suﬃcient to
masculinize the underlying circuitry, compatible with the
view that the underlying circuitry is sexually dimorphic.
In contrast, the performance of young men in tests typi-
cally showing a female advantage (verbal memory, visual
memory) was promoted by testosterone only after aroma-
tization to estradiol (Kampen and Sherwin, 1996; Cherrier
et al., 2003). Positive eﬀects of estrogens on cognition-
related circuitry in the PFC and on performance in working
memory tasks have also been conﬁrmed in young women
in a study combining positron emission tomography, a
battery of neuropsychological tests and pharmacological
manipulation of ovarian steroids, as well as in
menopausal women with or without hormone replacement
therapy (Berman et al., 1997; Keenan et al., 2001). In
contrast, results of studies comparing normal, control
young women and those with elevated testosterone levels
due to polycystic ovarian syndrome suggest that testos-
terone compromises performance in cognitive tests show-
ing a female advantage (verbal ﬂuency, verbal memory,
manual dexterity, visuospatial working memory), but has
no eﬀect on those showing a male advantage (mental
rotation, spatial visualization, spatial perception, percep-
tual speed) (Schattmann and Sherwin, 2007a,
Schattmann and Sherwin, 2007b). As permissible experi-
mental designs in humans do not enable rigorous testing
of hypotheses, it is diﬃcult to draw clear conclusions from
such studies, but they do indicate that sex hormones dif-
ferentially aﬀect human behavior and may be acting on a
sexually diﬀerentiated circuitry (Gillies and McArthur,
2010b).
Similar to the human data, animal behavioral studies
demonstrate that gonadal hormones inﬂuence
performance in cognitive tests that are reliant on the
PFC, although the eﬀects of gonadectomy and
treatment with estradiol or testosterone vary according
to sex and test (Ceccarelli et al., 2001; Gibbs, 2005).
Pre-clinical studies originally focused on the perfor-
mance-enhancing eﬀects of estradiol in ovariectomized
female rats and rhesus monkeys, which have been
correlated positively with eﬀects on the growth of
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2006; Hajszan et al., 2008). However, subsequent work
suggests that both estrogens and androgens may have
positive eﬀects on cognition and synapse remodeling in
the PFC of both sexes (Hajszan et al., 2008). Studies
looking speciﬁcally at the mesocortical dopaminergic
system have been performed principally in male rodents.
For example, castration increased the density of axons
positive for tyrosine hydroxylase immunoreactivity
(TH-IR) as well as extracellular resting DA levels in the
male rat medial prefrontal cortex (mPFC), and this eﬀect
was reversed by treatment with testosterone, not estradiol
(Kritzer, 2003; Kritzer and Creutz, 2008; Aubele and
Kritzer, 2011). Castration also impaired DA-dependent
meso-prefrontal functions such as operant spatial working
memory, T-maze acquisition and novel object recognition
acquisition in an androgen-, not estrogen-, dependent
manner (Kritzer et al., 2007). These data are consistent
with the human data where performance of certain
prefrontal tasks in men has been correlated with
circulating androgen, not estrogens (Cherrier et al.,
2003). Castration of male rats has also been reported to
cause a decline in prefrontal DA-dependent tests of
motivation. Notably, however, this eﬀect was reversed
by treatment with estradiol, not testosterone (Kritzer
et al., 2007). Yet other aspects of PFC function involving
impulsivity and reversal learning were unaﬀected by
castration or hormone treatment, and unrelated to PFC
dopaminergic innervation (Kritzer and Creutz, 2008).
These observations invite the speculation that sex
steroid hormones diﬀerentially inﬂuence discrete VTA
populations and their associated behaviors.
An androgenic rather than estrogenic inﬂuence on
certain aspects of mPFC function in male rats is
consistent with the ﬁnding that AR-immunoreactivity
(IR), not ER-IR, was found to co-localize with TH-IR in a
sub-set of VTA neurons which project to the prelimbic
area of the mPFC (Kritzer and Creutz, 2008), indicating
direct AR-mediated inﬂuences within dopaminergic neu-
rons. In contrast, ERb-IR predominated in the VTA dopa-
minergic neurons projecting to the primary motor cortex,
where castration reduced TH-IR density in an estrogen-,
not androgen-, dependent manner; in yet another set of
dopaminergic neurons projecting to the premotor cortex,
neither AR-IR nor ER-IR was detected, and sex hormone
manipulations failed to aﬀect dopaminergic innervation in
this area (Kritzer, 2003). These studies clearly emphasize
the diversity of the VTA dopaminergic populations in
terms of their hormone responsiveness, at least in males.
It is important to note, however, that conclusions regard-
ing hormonal responsiveness solely on the expression
of ARs or ERs should be drawn with caution because it
is now recognized that estrogens and androgens can
act rapidly at membrane receptors which may be distinct
from their classical intracellular nuclear receptors
(Srivastava et al., 2013). Equally, hormones could exert
their eﬀects indirectly via non-dopaminergic systems
involved in dopaminergic regulation.
Fewer studies have addressed hormonal inﬂuences
speciﬁcally on the mesocortical system in females.
Retrograde labeling studies have reported that thedistribution of AR in VTA dopaminergic neurons
projecting to the PFC in females is similar to that found
in males. In contrast, the non-dopaminergic cells in the
VTA which project to the PFC were found to be ERb-
positive and ERa-negative in males, but ERb-negative
and ERa-positive in females (Kritzer and Creutz, 2008).
The implications of these sex diﬀerences require further
investigation, but they indicate likely sex-speciﬁc eﬀects
of estradiol. Estradiol has been shown to aﬀect activity
in the mesocortical projections in female rats (McEwen
and Alves, 1999), but it remains to be determined whether
these diﬀer from eﬀects in males.Sex hormone inﬂuences during development
When the endogenous gonadal hormone environment is
equalized in adult male and female rodents by
gonadectomy, there are numerous examples where the
eﬀects of treatment with gonadal steroids (especially
estrogens) on learning, memory and their structural,
electrophysiological and neurochemical correlates, are
not the same in males and females (reviewed in (Gillies
and McArthur, 2010b)). As discussed under Section ‘Sex
hormone inﬂuences in adulthood’, this is exempliﬁed in
gonadectomized rats by the responsiveness of the
female, but not male, mesolimbic system to estradiol. Col-
lectively this body of evidence suggests a fundamental
sex dimorphism in the underlying circuitry. Many studies
have demonstrated that testosterone exposure of neona-
tal rat pups is a major driving force for brain mascu-
linization not only in the hypothalamus, but also in other
regions important for learning and memory, such as the
hippocampus, amygdala and bed nucleus of the stria ter-
minalis (Bangasser and Shors, 2007, 2008; McCarthy
et al., 2008; Arnold, 2009). In line with this hypothesis,
one study reported that perinatal exposure to testoster-
one in male rats is required to achieve normal levels of
DA in the frontal cortex at postnatal day 10 (Stewart
and Rajabi, 1994). However, whether the perinatal testos-
terone surge may also be a factor for sexual diﬀerentiation
of the adult VTA has yet to be fully investigated (Becker,
2009).
As views on the hormonal inﬂuences on brain sex
diﬀerentiation progress, early puberty is emerging as
another critical window when rising levels of sex
hormones may exert organizational inﬂuences on neural
pathways which have yet to complete their development
(Sisk and Zehr, 2005; Ahmed et al., 2008). The pubertal
rise in estrogens in females and testosterone in males
therefore provides further possibilities for imprinting brain
sex dimorphisms. The mesocortical dopaminergic system
most notably continues to develop into young adulthood
(Spear, 2000), but detailed knowledge of adolescent sex-
ual diﬀerentiation of this pathway is lacking. However,
some key observations indicate that puberty is an impor-
tant time when ovarian steroids contribute to feminization
of midbrain dopaminergic circuitry (Becker, 2009). For
example, the greater open-ﬁeld activity displayed by
female rats requires exposure to ovarian hormones at
the time when gonadal steroidogenesis is ﬁrst activated
transiently in females (around 2 weeks of age) or at the
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open-ﬁeld activity may be suppressed (masculinized) by
perinatal hormonal exposure (Stewart and Cygan,
1980). As adolescence is a time when sex-speciﬁc
changes occur in behaviors known to involve dopaminer-
gic systems, including mood, emotional responses,
aggression and risk-taking, (Sisk and Zehr, 2005), a bet-
ter understanding of hormonal inﬂuences should be a
priority.
Genomic inﬂuences
The perinatal testosterone surge in rats and mice begins
around gestational day 17, 4–5 days before parturition.
Interestingly, primary mesencephalic cultures derived
from rats or mice at embryonic day 13, prior to
signiﬁcant changes in circulating testosterone levels,
develop sex-speciﬁc characteristics in the absence of
sex steroid hormones, as determined by the number of
cells expressing tyrosine hydroxylase (the rate-limiting
step in DA synthesis indicative of dopaminergic
neurons), DA levels in the culture medium and [3H]DA
uptake (a measure of DAT activity in dopaminergic
nerve terminals) (Sibug et al., 1996). These and other
observations demonstrate that factors other than sex ste-
roid hormones contribute to sexual diﬀerentiation of the
brain, and midbrain dopaminergic neurons in particular.
Several lines of evidence suggest that the sex chromo-
somes themselves contribute a genetic component in
addition to the epigenetic (hormonal) component to
engender biological sex diﬀerences (Arnold, 2009). Of
note, expression of the SRY gene (the sex determining
region of the Y chromosome), which was thought to have
a developmentally restricted role in sex determination by
directing formation of the testes, has now been identiﬁed
in a number of adult male non-reproductive tissues includ-
ing the brain in humans (Ngun et al., 2011), rats and mice
(Mayer et al., 2000; Dewing et al., 2006). Furthermore,
the SRY protein is expressed in VTA and SNc neurons
in post-mortem human and rat brain specimens, where
it co-localizes with a subset of neurons expressing tyro-
sine hydroxylase (Dewing et al., 2006; Czech et al.,
2012). SRY has also been shown to positively regulate
the expression of enzymes involved in DA synthesis
(Milsted et al., 2004; Czech et al., 2012) and silencing
SRY mRNA reduced DA neuron number in the rodent
male SNc, which also compromised SNc (motor) function
(Dewing et al., 2006). It remains to be determined
whether SRY contributes to sex diﬀerences in VTA struc-
ture and function. Interestingly, however, investigations
using the ‘four core genotype’ mouse model, where
genetic sex and gonadal phenotype can be separated
(De Vries et al., 2002), found that XX mice (genetic
females) showed faster food-reinforced instrumental habit
formation than XY mice (genetic males). Moreover, this
result occurred regardless of the associated hormonal
environment (ovarian or testicular gonadal phenotype)
or expression of the SRY gene (Quinn et al., 2007). These
ﬁndings raise the possibility that the sex chromosome
complement other than SRY may also be inﬂuencing
sex diﬀerences in brain function, including DA-dependent
habit-driven behavior. This could be due to direct eﬀectsof the Y chromosome genes, to incomplete silencing of
X chromosome genes in females, or to sex diﬀerences
in the genomic imprinting of X-chromosome genes
(Arnold and Burgoyne, 2004).
In summary, a full understanding of the developmental
mechanisms which underpin sex diﬀerentiation of the
mesolimbic and mesocortical dopaminergic pathways is
notably lacking. This knowledge does, however, have
translational relevance for brain disorders involving
midbrain dopaminergic systems where their etiology
involves a neurodevelopmental component as well as a
sex bias (see Section ‘Sex diﬀerences in dopaminergic
malfunction: impact of stress and neurobiological
programing’).SEX DIFFERENCES IN DOPAMINERGIC
MALFUNCTION: IMPACT OF STRESS AND
NEUROBIOLOGICAL PROGRAMING
Malfunction of the midbrain dopaminergic systems
underpins many neurological and psychiatric disorders,
including schizophrenia (Lewis and Levitt, 2002), atten-
tion deﬁcit/hyperactivity disorder (Solanto, 2002), autism
and autism spectrum disorders (Anderson et al., 2008),
substance abuse (Melichar et al., 2001), anxiety and
depression (Dunlop and Nemeroﬀ, 2007). All of these
conditions are characterized by substantial sex diﬀer-
ences in their prevalence and/or nature (Ngun et al.,
2011; McCarthy et al., 2012). In schizophrenia, for exam-
ple, the age at onset occurs several years earlier, the risk
may be greater, the pathological symptoms may be more
severe, and the prognosis may be poorer in men com-
pared with women (Jablensky, 2000; Aleman et al.,
2003). For autism there is a much higher male:female
ratio in its prevalence (Baron-Cohen et al., 2005). Sex dif-
ferences are observed in all phases of drug abuse, with
women escalating more rapidly to addiction, and being
more likely to relapse following abstinence (Carroll
et al., 2004; Lynch, 2006; Becker and Hu, 2008). Anxiety
disorders and depression are also widely reported to be
more prevalent in women (Seeman, 1997). These diﬀer-
ences highlight the need to understand the mechanisms
which underlie such sex bias in disease which will provide
insight into the development of new therapies to meet the
speciﬁc needs for men and women (Solomon and
Herman, 2009).
In all cases, neurobiological factors appear to play an
important role in driving sex bias in brain disorders
(Kaminsky et al., 2006; Gabory et al., 2009; Lai et al.,
2013). The interaction of hormonal and genetic factors
during development and/or adulthood, to create sex
dimorphisms in normal brain circuitries regulating behav-
ior (Section ‘Mechanisms underlying sexual diﬀerentiation
of the VTA dopaminergic systems’) may contribute to dif-
ferential susceptibilities to malfunction. Another factor is
environment, with a particular emphasis on the eﬀects
of chronic stress, which, as an established risk factor for
developing neurological and psychiatric disease
(McEwen, 1998, 2009; Sapolsky, 2005), may diﬀerentially
aﬀect males and females (Goel and Bale, 2009). Indeed,
a recent review proposed that sex-speciﬁc environmental
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brain sex diﬀerentiation, along with hormonal and geno-
mic inﬂuences (McCarthy and Arnold, 2011). In the con-
text of sex bias in VTA-related disorders, it is therefore
important to understand the impact of stress upon the
mesolimbic dopaminergic systems.
The VTA as a target for stress in adulthood
The physiological stress response is typically thought of
as an activation of the sympathetic nervous system in
order to mount immediate eﬀects on metabolic,
cardiovascular and immune systems; this is closely
followed by activation of the hypothalamo–pituitary–
adrenal (HPA) axis to increase circulating levels of
glucocorticoids (cortisol in humans; corticosterone in
rodents) (Buckingham, 2006). These glucocorticoid hor-
mones support and prolong physiological stress
responses, which are protective, enabling the individual
to survive the stressor. Ultimately, the raised glucocorti-
coid levels exert a negative feedback on the brain and
anterior pituitary gland to limit or resolve the body’s reac-
tion to stress and prevent exaggerated or prolonged acti-
vation of the HPA axis, which, if not curtailed, become
maladaptive and potentially pre-dispose to disease
(McEwen, 1998; Sapolsky et al., 2000; de Kloet et al.,
2005; McEwen and Gianaros, 2010). Less widely
acclaimed, but nonetheless critical for behavioral
responses to stress, is activation of the VTA dopaminer-
gic neurons and stimulation of the process of learning
and memory by aversive events (Thierry et al., 1976;
Roth et al., 1988; Abercrombie et al., 1989; Trainor,
2011). These pathways are better known for their percep-
tion of rewarding rather than aversive stimuli, but this
function is likely to be distinct from, but co-operative with,
those which perceive non-rewarding events (Brischoux
et al., 2009; Bromberg-Martin et al., 2010; Roeper,
2013), and are likely to involve a distinct subset of dopa-
minergic neurons projecting to the amygdala (Guarraci
et al., 2000; Sapolsky, 2009). Hence, the VTA dopaminer-
gic circuitry plays a key role in enabling the storage and
recall of stressful events, which can then be matched with
appropriate behaviors when stressors are encountered
subsequently. Such higher cognitive functions are, there-
fore, key components in enabling the individual to develop
stress-coping strategies.
Notably, in humans and experimental species,
marked sex dimorphisms are seen in stress sensitivity,
as well as in physiological and behavioral responses to
stress (Bowman, 2005; Kudielka and Kirschbaum, 2005;
Luine et al., 2007; Goel and Bale, 2009; Gillies and
McArthur, 2010b; McEwen, 2010), which are character-
ized typically as ‘fright, ﬂight or ﬁght’ in males, but ‘tend
and befriend’ in females (Taylor et al., 2000). Stress also
induces sex- and region-speciﬁc patterns of structural
remodeling in the brain, which are correlated with eﬀects
on cognitive and emotional function. For example, in male
rats acute stress has been reported to increase dendritic
branching and spine synapses in the hippocampus, but to
decrease these parameters in the prefrontal cortex, while
enhancing vigilance and learning, commensurate with
survival in the wild (Leuner and Shors, 2013). Acutestress in females produced opposite responses: dendritic
branching and spine synapses were reduced in the hippo-
campus, but increased in the prefrontal cortex in parallel
with withdrawal behavior (commensurate with retreat to
safety in the wild) and detrimental eﬀects on learning
and memory (Leuner and Shors, 2013). Investigations
which speciﬁcally focus on the male VTA systems have
documented how stress and the glucocorticoid stress hor-
mones impact on the adult mesolimbic and mesocortical
dopaminergic systems at behavioral, biochemical, neuro-
chemical and molecular levels (Piazza and Le Moal,
1996; Lindley et al., 1999; Krishnan et al., 2007, 2008;
Trainor, 2011; Cabib and Puglisi-Allegra, 2012; Lemos
et al., 2012; Barik et al., 2013; Niwa et al., 2013;
Roeper, 2013). A simple summary of the ﬁndings of such
studies is complicated by the complexity of VTA dopami-
nergic responses stress, which vary according to the nat-
ure of the stressor (acute versus chronic; physical,
psychological or social; repeated homotypic vs. variable)
and whether eﬀects on the mesocortical or mesolimbic
pathways were investigated. Not surprisingly, therefore,
the literature contains apparent contradictions as to
whether stressors activate or suppress dopaminergic
activity. However, some recent elegant studies in male
mice have shed important light on the key role played
by dopaminergic neurons in the VTA in stress vulnerabil-
ity. Based on the premise that stressful events adversely
aﬀect behaviors and cause pathological change in the
human and rodent brain only in a sub-population of indi-
viduals, this work identiﬁed unique molecular signatures
within the mouse mesolimbic dopaminergic circuit which
were speciﬁcally associated with either vulnerability or
susceptibility using a social defeat paradigm which mod-
els depressive-like behavior (Krishnan et al., 2007,
2008). These data highlight potential DA-dependent
mechanisms in males which could underpin an individ-
ual’s susceptibility to succumb to disease. Although paral-
lel studies have not been performed in females, some
behavioral responses indicate that the eﬀects of stress
on mesocorticolimbic dopaminergic pathways are sexu-
ally dimorphic. For example, stress may increase the sen-
sitivity of certain addictive behaviors in females but not
males (McCormick et al., 2005); social isolation stress
may be anxiogenic in females, but anxiolytic in males
(Trainor, 2011); chronic stress impaired male perfor-
mance in visual and spatial memory tasks, whereas
female performance was unaﬀected or even enhanced
(Bowman et al., 2003). Additionally, various types of
stress have been shown to alter dopaminergic activity in
the mPFC and striatum in one sex but not the other
(Bowman et al., 2003; Dalla et al., 2008). In view of the
impact which such diﬀerences could have on our under-
standing of disease susceptibility, more research in
females and male/female diversity should be a priority
(Beery and Zucker, 2011).
Neurobiological programing of developing VTA
dopaminergic systems
It is increasingly recognized that, in many mammalian
species, early life experience inﬂuences an individual’s
sensitivity to stress as well as the pre-disposition to
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and Nemeroﬀ, 2002; Lupien et al., 2009; McEwen, 2010;
Bale et al., 2010). In humans, for example, retrospective
studies and, more recently, prospective studies, docu-
ment the increased occurrence of emotional problems in
children and adolescents whose mothers experienced
emotional stress during pregnancy (Talge et al., 2007).
Exposure to various types of stressors in utero, such as
obstetric complications, psychological stress, natural
disasters or intra-uterine infections, has also been associ-
ated with an increased risk of developing anxiety, depres-
sive states, schizophrenia, ADHD, autism and substance
abuse (Melichar et al., 2001; Koenig et al., 2002; Ben
Amor et al., 2005; Phillips et al., 2005; Szpir, 2006;
Khashan et al., 2008; Weinstock, 2011). These common-
est brain disorders typically exhibit a neurodevelopment
component and a sex bias, as well as an involvement of
midbrain dopaminergic circuitry. Collectively, these obser-
vations support the hypothesis that the developing VTA
dopaminergic systems have a particular susceptibility to
neurobiological programing by early environmental chal-
lenge, which diﬀerentially impacts male and female
brains, thereby leading to sexual dimorphism in suscepti-
bility to DA-associated brain disorders. This is in accord
with reports that biological programing of the brain and
other structures by gestational exposure to stress/gluco-
corticoids is sex-speciﬁc (Seckl and Holmes, 2007). Fur-
ther support is oﬀered by a clinical study involving
positron emission tomography, which demonstrated that
mesolimbic dopaminergic activity was altered in a group
of young women, not men, who had experienced early life
adversity, compared with those who did not report such
experiences (Pruessner et al., 2004). It was proposed that
such changes could potentially contribute to the greater
susceptibility to developing depressive conditions which
is found in this group of females (Vythilingam et al.,
2002; Heim and Binder, 2012).
Susceptibility of the developing VTA dopaminergic
systems to disruption by adverse environments in utero
is directly supported by studies employing a variety of
animal models of perinatal stress, including maternal
exposure to restraint (psychogenic) stress, hypoxia,
immune challenge and malnutrition, which alter
dopaminergic activity and VTA-dependent functions in
the adult oﬀspring, including learning, locomotor activity
and addictive behaviors (Henry et al., 1995; Boksa and
El-Khodor, 2003; Kippin et al., 2008; Meyer and Feldon,
2009; Gatzke-Kopp, 2010; Rodrigues et al., 2011). These
investigations have largely been carried out in male rats
or mice, despite numerous reports that early-life pro-
graming of metabolic, endocrine, and immune systems,
as well as brain function and behavior, is sexually dimor-
phic in these species (Bowman et al., 2004; Luine et al.,
2007; Seckl and Holmes, 2007; Schwarz and Bilbo,
2012). However, sex diﬀerences in VTA programing have
been proposed on the basis that gestational stress was
found to be a sex-speciﬁc risk factor for diﬀerent aspects
of substance abuse in pre-clinical models (Thomas et al.,
2009). The animal data therefore provide some support
for the view that environmental perturbations in utero
may diﬀerentially aﬀect the developmental trajectories inthe male and female VTA, leading to a sex bias in the ten-
dency to malfunction in later life.
An understanding of the mechanisms whereby early
environmental insults have enduring eﬀects on the
normal functioning of the VTA dopaminergic systems is
clearly of paramount importance. A critical common
factor in all stress responses is the release of
glucocorticoid hormones by the maternal/fetal HPA axis,
which are thought to be key players in neurobiological
programing in humans and experimental species (Owen
et al., 2005; Van den Bergh et al., 2005; Seckl and
Holmes, 2007; Davis and Sandman, 2010). Our own work
has demonstrated that the rodent VTA systems are direct
targets for neurobiological programing by brief exposure
to the synthetic glucocorticoid, dexamethasone, toward
the end of gestation, with some similarities, but also nota-
ble diﬀerences, between males and females. Speciﬁcally,
antenatal glucocorticoid treatment (AGT) increased the
adult numbers of dopaminergic neurons in the VTA (by
50%) in both sexes (Fig. 2 A, D, F), and this was accom-
panied by an increase (by 40%) in dopaminergic inner-
vation throughout the ventral striatum (NAc core and
shell), as well as the dorsal striatum (caudate, putamen)
(McArthur et al., 2005, 2007a) (Fig. 4). Increased neuro-
nal survival did not, however, lead to an increase in basal
extracellular DA levels in the NAc in either sex. This could
be explained by the marked increase in striatal levels of
D2 receptors in AGT-exposed animals (Fig. 4A), which
paralleled the increase in terminal density and may
represent an adaptation at the level of pre-synaptic
auto-inhibitory (D2) receptors to stabilize baseline activity
in the face of an AGT-expanded population. Despite
these similarities in males and females, AGT-induced
changes in other synaptic markers of dopaminergic trans-
mission were profoundly sexually dimorphic (Fig 4). For
example, the DAT protein is another presynaptic marker,
often taken as an indicator of terminal density, which is a
key regulator of synaptic levels of DA. DAT binding den-
sity in the NAc (core and shell), as well as the dorsal stri-
atum (caudate/putamen), was similar in control male and
female rats, but in AGT-exposed animals its levels were
dramatically increased in line with terminal density in
males (by 62–140%, depending on region), but
decreased (by 80%) in females (Fig. 4A) (Virdee
et al., 2013). Consequently, DAT levels diﬀered by an
order of magnitude in males and females as a result of
AGT. Although, surprisingly, this did not aﬀect baseline
extracellular levels, AGT dramatically enhanced in vivo
amphetamine-stimulated DA eﬄux in males, but reduced
it in females (Figs. 1 and 4) (Virdee et al., 2013). As the
DA releasing eﬀects of amphetamine arise primarily from
its ability to bind to DAT (Fleckenstein et al., 2007), and
are commonly regarded as a primary indicator of DA tone,
these ﬁndings suggest that AGT profoundly alters meso-
limbic activity in a sexually dimorphic manner (increased
in males, decreased in females).
Behavioral studies provide some support of this
hypothesis. For example, in male, but not female,
progeny AGT exaggerated the ability of prepulses to
inhibit the startle reﬂex (Virdee et al., 2013), which is
indicative of enhanced pre-attentional processing
Fig. 4. Schematic summary of the directional change in neurobiological and behavioral indicators of VTA dopaminergic activity in adult male and
female rats after antenatal glucocorticoid treatment (AGT). Male and female rats exposed to AGT (dexamethasone, 0.5 lg/ml, in drinking water on
gestational days 16–19) and controls (dams received normal drinking water) were tested in adulthood. Neurobiological programing (A): VTA
Dopaminergic cell counts and striatal ﬁber density (NAc core and shell) were assessed after immunostaining for tyrosine hydroxylase. Expression
levels of DA receptors (D1, D2) and DAT (NAc core and shell) were assessed using autoradiography. DA eﬄux was measured as described in
Fig. 1. Behavioral programing (B): Electrophysiological measurements in vivo included extracellular recordings from individual putative DA neurons
in the VTA of adult male rats and assessments of spike width, ﬁring rate, inter-spike intervals and percentage of action potentials in spike bursts.
Tests of conditioned behavior involved Pavlovian learning in response to appetitive cues predictive of food (autoshaping) and cocaine self-
administration using a ﬁxed schedule of reinforcement with ascending doses of cocaine. Sensorimotor gating was tested by analyzing eﬃcacy of a
weak sensory stimulus to inhibit a reﬂexive motor response to a subsequent intense sensory event (pre-pulse inhibition of acoustic startle).
Locomotor activity induced by intra-peritoneal injections of amphetamine (0, 0.2, 0.4, 0.8 and 1.2 mg/kg) was recorded using photocell chambers.
For full details see Virdee et al. (2013).
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the fall in NAc DA levels associated with the startle in
male rats (Humby et al., 1996), this ﬁnding is compatible
with the AGT-induced enhancement of mesolimbic dopa-
minergic activity in males, but not females (Virdee et al.,
2013). In contrast, locomotor response to novelty (an indi-
cator of motivational arousal dependent on mesolimbic
and mesostriatal dopaminergic systems (Jones and
Robbins, 1992)) was attenuated by AGT in females (com-
patible with the AGT-induced reduction of mesolimbic
dopaminergic activity), but not males. However, despite
the signiﬁcant and opposite eﬀect of AGT in males and
females to alter amphetamine-stimulated DA eﬄux in
the NAc (Figs. 1 and 4A), amphetamine-induced locomo-
tor activity was remarkably unaﬀected by AGT in both
sexes (Fig. 4B) (Virdee et al., 2013). This unexpected
result may be explained by our ﬁnding that AGT up-regu-
lated striatal post-synaptic D1 receptors in females
(Fig 4A) (Virdee et al., 2013), which may serve to pre-
serve excitability in D1-expressing GABAergic medium
spiny output neurons (MSNs) (Lobo and Nestler, 2011)
in the face of reduced mesolimbic activity and, hence,
maintain basal ganglia output within normal limits. In stark
contrast, AGT down-regulated striatal post-synaptic D1
receptors in males (Fig. 4A) (Virdee et al., 2013), which,
along with the concurrent increased mesolimbic activity,
could serve to normalize basal ganglia output. A similar
argument may explain why the substantial AGT-induced
neurobiological changes in the mesolimbic dopaminergic
system also failed to aﬀect other behaviors, including
cocaine self-administration and learning in response toappetitive cues (Fig. 4B) (Virdee et al., 2013), which are
known to be reliant on mesolimbic dopaminergic trans-
mission (Jones and Robbins, 1992; Campbell et al.,
1997; Parkinson et al., 2002; Dalley et al., 2005). Collec-
tively, these ﬁndings demonstrate that apparent behav-
ioral normality in animals exposed to glucocorticoids in
utero is achieved by AGT-induced adaptive mechanisms
in the VTA circuitry which are diﬀerent, often opponent,
in males and females.
In our studies we have used a dose of
dexamethasone (0.075 mg/kg/day) (McArthur et al.,
2006, 2007b) at or below the clinical dose commonly used
in perinatal medicine (0.2 mg/kg/day (Ballard and
Ballard, 1995). The drug is administered non-invasively
via the dam’s drinking water on gestational days 16–19,
thereby avoiding any confounding eﬀects of injection
stress, and investigations in adult animals were done
under basal, non-stressful, conditions which are thought
to probe intrinsic functional connectivity (Van den
Heuvel and Pasterkamp, 2008). Other studies, using
similar levels of dexamethasone exposure in utero,
corroborate our ﬁndings that open-ﬁeld locomotor
activity was lowered in females, but unaﬀected in males
(Kreider et al., 2005), and that behavioral deﬁcits after
administration in the drinking water are relatively mild or
absent (Hauser et al., 2006, 2009). In contrast, there
are reports in the literature that AGT has more marked
long-term eﬀects, including anxiety, depressive-like
behavior, drug-seeking behavior and a reduction in
mesolimbic dopaminergic transmission in males
(Welberg and Seckl, 2001; Oliveira et al., 2006;
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these studies have generally employed a higher dose of
dexamethasone (1 mg/kg on gestational days 18 and 19
administered subcutaneously) and/or have observed
behavioral eﬀects only after either a prolonged exposure
to a battery of stressors in adulthood or inherently
stressful aspects within the behavioral test. A number of
studies have also used pregnant rats supplied by
commercial suppliers, which were received into the local
animal facility after experiencing transportation stress just
a matter of days prior to experimentation (Diaz et al.,
1997; Oliveira et al., 2006). The AGT regimen and any
association with an additional stressful background at
any time-point would, thus, appear to be major factors
contributing to contradictions in the literature. The ﬁndings
do, however, serve to illustrate that neurobiological
end-points appear to be more sensitive than behavioral
end-points at detecting change. They also demonstrate
that behavioral normality is achieved by the midbrain
dopaminergic network operating outside its normal limits,
and is, therefore, in a state of allostasis, or ‘stability through
change’ (McEwen, 1998; Beauchaine et al., 2011). While
these AGT-induced adaptations or compensatory
mechanisms confer enduring behavioral resilience in
certain situations, they may ultimately contribute to the
allostatic burden which could represent a pre-disposition
to (psych)pathology when further challenged in later life
(Brake et al., 1997). As the mechanisms which confer
resilience or susceptibility to early environmental challenge
occur via sexually dimorphic capacities for molecular
adaptations within the VTA dopaminergic systems
(Fig. 4), they oﬀer intriguing possibilities for mechanisms
which could underpin the sex bias commonly found in
midbrain DA-associated disorders.SUMMARY
Our understanding of the function of the VTA and, indeed,
the brain, derives largely from investigations of the male
species. Here, we have reviewed the evidence from
both basic science and human data, which indicates
notable structural and functional diﬀerences in the VTA
of females compared with males. The likelihood of a
biological basis for sexual diversity in the VTA systems
raises important questions regarding sex bias in
brain disorders associated with their malfunction.
Furthermore, we have highlighted marked sex
dimorphisms in the capacity of the VTA systems to
adapt or compensate for perturbations in the early-life
environment, which are known to increase the risk of
malfunction in midbrain dopaminergic pathways and,
hence, an individual’s susceptibility to develop
psychopathologies in later life. In particular, we have
identiﬁed sex-speciﬁc mechanisms of glucocorticoid
neurobiological programing in the mesolimbic DA
systems that diﬀerentially aﬀect speciﬁc male and
female behaviors. These relate to female behaviors
(motivational arousal), which are altered in depression
(more prevalent in women (Kessler, 2003)) and male
behaviors (pre-attentional processing/PPI), which are
aﬀected in male, but not female, schizophrenic subjects(Kumari et al., 2008). These observations add to the evi-
dence that susceptibility of the relevant circuitry to envi-
ronmental challenge is sexually dimorphic in a
psychopathological context (Bale, 2006). Elucidation of
the mechanisms promoting these dimorphisms is an
important future challenge and may shed light on sex dif-
ference in disease mechanisms and, hence novel sex-
speciﬁc therapeutic targets. The data also highlight how
the midbrain dopaminergic (DA-ergic) systems and the
disorders associated with their dysfunction represent
excellent prototypes for advancing the ﬁeld of sex dimor-
phisms in brain structure, function, and behavior.Acknowledgements—The authors’ research is funded by The
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